Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

5.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.4K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

77.8K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
77.8K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

5.1K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Editorial: Current chemical approaches in combating neuroinflammation in Alzheimer's disease (AD).

Frontiers in aging neuroscience·2025
Same author

Radical-induced lipid oxidation produces a torrent of leukotriene-like agonists in severe asthma.

The Journal of allergy and clinical immunology·2025
Same author

Transient receptor potential vanilloid type 4 channels mediate bladder cancer cell proliferation, migration, and chemoresistance.

The Journal of pharmacology and experimental therapeutics·2025
Same author

Endothelial metabolic zonation in the vascular network: a spatiotemporal blueprint for angiogenesis.

American journal of physiology. Heart and circulatory physiology·2025
Same author

Leukotrienes: Bridging the Inflammatory Gap in Asthma and Inflammatory Bowel Diseases (IBD).

Comprehensive Physiology·2025
Same author

Microbiota in Gut-Heart Axis: Metabolites and Mechanisms in Cardiovascular Disease.

Comprehensive Physiology·2025

相关实验视频

Updated: Jun 17, 2025

Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay
09:03

Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay

Published on: June 30, 2023

886

一个TRP病态血管生成和血管正常化.

Venkatesh Katari1, Kesha Dalal1, Ravi K Adapala1

  • 1Department of Physiology and Pharmacology, The University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, USA.

Comprehensive Physiology
|August 7, 2024
PubMed
概括

向通道,特别是TRPV4,提供了一种新的方法来规范病态血管生成. 该战略旨在克服当前针对癌症和眼睛疾病的抗VEGF疗法的局限性.

更多相关视频

Translating Ribosome Affinity Purification TRAP for RNA Isolation from Endothelial Cells In Vivo
08:53

Translating Ribosome Affinity Purification TRAP for RNA Isolation from Endothelial Cells In Vivo

Published on: May 25, 2019

11.8K
In Vitro Model of Coronary Angiogenesis
08:03

In Vitro Model of Coronary Angiogenesis

Published on: March 10, 2020

7.7K

相关实验视频

Last Updated: Jun 17, 2025

Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay
09:03

Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay

Published on: June 30, 2023

886
Translating Ribosome Affinity Purification TRAP for RNA Isolation from Endothelial Cells In Vivo
08:53

Translating Ribosome Affinity Purification TRAP for RNA Isolation from Endothelial Cells In Vivo

Published on: May 25, 2019

11.8K
In Vitro Model of Coronary Angiogenesis
08:03

In Vitro Model of Coronary Angiogenesis

Published on: March 10, 2020

7.7K

科学领域:

  • 生理学 生理学 生理学
  • 分子生物学分子生物学
  • 病理学 病理学 病理学

背景情况:

  • 失控的血管新生导致癌症和AMD等疾病.
  • 目前的抗VEGF疗法面临耐药性和不良影响.
  • 需要新的策略来准病理性血管生成.

研究的目的:

  • 审查短暂受体潜能 (TRP) 通道在病态血管生成中的作用,重点关注TRPV4.
  • 探索TRPV4的下游信号通路及其由瘤微环境的调制.
  • 突出内皮TRPV4作为血管正常化潜在的治疗点.

主要方法:

  • 关于通道和血管生成的文献综述.
  • 专注于TRPV4在内皮细胞中的作用.
  • 分析瘤微环境对TRPV4信号传递的影响.

主要成果:

  • 通道,特别是TRPV4,是血管生成的关键调节者.
  • 瘤微环境通过Rho/YAP/VEGFR2通路调节TRPV4活动.
  • 内皮TRPV4影响病态血管生成和血管正常化.

结论:

  • 内皮TRPV4为血管正常化提供了一个有前途的治疗点.
  • TRPV4调制为抗VEGF策略提供了一个替代方案.
  • 向TRPV4可以改善癌症和新血管眼部疾病的治疗方法.